DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lucentis (Ranibizumab) - Current Clinical Trials

 
 



Lucentis Related Clinical Trials

Ranibizumab for the Inhibition of Neovascularization in Pterygia [Recruiting]

Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration [Recruiting]

Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion [Recruiting]

Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus [Not yet recruiting]

Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma [Recruiting]

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-Based Retreatment [Recruiting]

20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD) [Recruiting]

Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery [Recruiting]

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1 [Recruiting]

Lucentis in Advanced Macular Degeneration [Recruiting]

LUCAS (Lucentis Compared to Avastin Study) [Recruiting]

French Evaluation Group Avastin Versus Lucentis [Recruiting]

Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE 2) [Recruiting]

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD) [Recruiting]

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) [Recruiting]

Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy [Recruiting]

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema [Recruiting]

Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema [Recruiting]

A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) [Recruiting]

Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME) [Recruiting]

Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis [Recruiting]

Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Recruiting]

Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy [Recruiting]

Lucentis as an Adjuvanct Therapy With TTT-ICG Based in Choroidal Melanoma [Recruiting]

Targeted Laser With Lucentis 0.5mg Verses Lucentis 0.5mg Monotherapy for Ischemic Central Vein Occlusion [Recruiting]

Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis) [Recruiting]

Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2) [Recruiting]

Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) - Correlation With Lucentis(R) Therapy [Recruiting]

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD [Recruiting]

Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema [Recruiting]

Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-Related Macular Degeneration (AMD) [Recruiting]

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization [Recruiting]

Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration [Recruiting]

Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema [Recruiting]

Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema [Recruiting]

A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD [Recruiting]

Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration [Recruiting]

Lucentis for Age-Related Macular Degeneration Pigment Epithelial Detachments [Recruiting]

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy [Recruiting]

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD [Recruiting]

Changes in Retinal Function After Intravitreal Ranibizumab for Age-Related Macular Degeneration [Recruiting]

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration [Recruiting]

The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study [Recruiting]

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial) [Recruiting]

Lucentis for Cystoid Macular Edema for Non-Ischemic Retinopathy [Not yet recruiting]

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma [Recruiting]

Lucentis (Ranibizumab) for Eales' Disease [Recruiting]

Study Comparing Two Doses of Ranibizumab in the Treatment of Clinically Significant Diabetic Macular Edema [Recruiting]

Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD [Recruiting]

A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD [Recruiting]

Lucentis Versus Mitomycin C During Glaucoma Surgery [Recruiting]

Comparison of Age-Related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial [Recruiting]

Lucentis for New Onset Neovascular Glaucoma [Not yet recruiting]

Second Line Therapy to Treat Age-Related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself [Available]

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) [Not yet recruiting]

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments [Not yet recruiting]

A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO [Recruiting]

Ranibizumab to Treat CNVs in Patients With PXE [Recruiting]

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy [Recruiting]

Evaluation of Dosing Interval of Higher Doses of Ranibizumab [Recruiting]

Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion [Recruiting]

Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration [Not yet recruiting]

Lucentis for Inflammatory Macular Edema Trial [Recruiting]

Ranibizumab for Neovascularization in Sickle Cell Retinopathy [Recruiting]

Study Evaluating Genotypes Using Lucentis [Recruiting]

Use of Ranibizumab With Mitomycin C During Trabeculectomy [Recruiting]

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy [Recruiting]

Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth [Recruiting]

Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth [Recruiting]

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) [Recruiting]

Ranibizumab Therapy for Non-Arteritic Ischemic Optic Neuropathy [Recruiting]

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma [Recruiting]

Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma [Recruiting]

Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab [Recruiting]

Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery [Recruiting]

Subretinal Lucentis for Hemorrhagic AMD [Recruiting]

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-VEGF Treatment in Patients With Age-Related Macular Degeneration [Recruiting]

Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging [Recruiting]

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-Related Macular Degeneration [Recruiting]

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration [Recruiting]

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion [Recruiting]

Efficacy Study of Lucentis in the Treatment of Retinoblastoma [Recruiting]

Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration [Not yet recruiting]

Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion [Recruiting]

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome [Recruiting]

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration [Not yet recruiting]

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) [Recruiting]

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO) [Recruiting]

The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema [Recruiting]

Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis [Not yet recruiting]

Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. [Not yet recruiting]

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy [Recruiting]

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy [Recruiting]

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab [Recruiting]

Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision [Recruiting]

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study [Recruiting]

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab [Recruiting]

Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME [Not yet recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014